Comparing Performance of Universal Health Care Countries, 2020 is a new study that compares the performance of Canada’s health-care system to its international peers. The data shows that despite Canada being among the most expensive universal-access health-care systems in the OECD, the country has some of the lowest numbers of doctors, hospital beds, medical technologies, and the longest wait times.

Biologics and Biosimilars: A Primer finds that Canadian patient access to potentially life-saving biologic medicines is comparatively limited because Canada’s protection of intellectual property in the life sciences—including biology and biochemistry—lags behind other industrialized countries.